|
|
Volumn 4, Issue 6, 2002, Pages 403-404
|
|
HMG CoA reductase inhibitors and PPAR-alpha activators: are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELL RECEPTOR;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
TRANSCRIPTION FACTOR;
ARTICLE;
BLOOD;
CORONARY ARTERY DISEASE;
HUMAN;
CHOLESTEROL, HDL;
CORONARY DISEASE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
TRANSCRIPTION FACTORS;
|
|
EID: 0036835450
PISSN: 15233804
EISSN: None
Source Type: Journal
DOI: 10.1007/s11883-002-0041-3 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
